Agentes antimicrobianos: una elección cada vez más amplia.

Same author

Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.

The Journal of antimicrobial chemotherapy·2001

Same author

Workshop Executive Summary Report: Post-resuscitative and initial Utility in Life Saving Efforts (PULSE): June 29-30, 2000; Lansdowne Resort and Conference Center; Leesburg, VA.

Circulation·2001

Same author

Cell-autonomous expression of barley Mla1 confers race-specific resistance to the powdery mildew fungus via a Rar1-independent signaling pathway.

The Plant cell·2001

Same author

Beyond the exchange--the future of B2B.

Harvard business review·2001

Same author

New restraint standards will change your practice.

ED management : the monthly update on emergency department management·2001

Same author

The in vitro activity of ABT773, a new ketolide antimicrobial agent.

The Journal of antimicrobial chemotherapy·2000

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Agentes antimicrobianos: una elección cada vez más amplia.

Videos de Conceptos Relacionados

Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.

Workshop Executive Summary Report: Post-resuscitative and initial Utility in Life Saving Efforts (PULSE): June 29-30, 2000; Lansdowne Resort and Conference Center; Leesburg, VA.

Cell-autonomous expression of barley Mla1 confers race-specific resistance to the powdery mildew fungus via a Rar1-independent signaling pathway.

Beyond the exchange--the future of B2B.

New restraint standards will change your practice.

The in vitro activity of ABT773, a new ketolide antimicrobial agent.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Agentes antimicrobianos: una elección cada vez más amplia.

Videos de Conceptos Relacionados

Artículos Relacionados

Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.

Workshop Executive Summary Report: Post-resuscitative and initial Utility in Life Saving Efforts (PULSE): June 29-30, 2000; Lansdowne Resort and Conference Center; Leesburg, VA.

Cell-autonomous expression of barley Mla1 confers race-specific resistance to the powdery mildew fungus via a Rar1-independent signaling pathway.

Beyond the exchange--the future of B2B.

New restraint standards will change your practice.

The in vitro activity of ABT773, a new ketolide antimicrobial agent.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.